riluzole 5 MG/ML Oral Suspension [Tiglutik]
- RxCUI
- 2059266
- RxNorm name
- riluzole 5 MG/ML Oral Suspension [Tiglutik]
- Display name
- riluzole 5 MG/ML Oral Suspension [Tiglutik]
- Full name
- riluzole 5 MG/ML Oral Suspension [Tiglutik]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:04
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TIGLUTIK | RILUZOLE | Italfarmaco SPA | 20b7165a-eb4d-42a0-b2d8-16eff90a214e | 2026-07-29 | 2059266 | |
| TIGLUTIK | RILUZOLE | EDW PHARMA, INC | 75d68f19-4208-109e-e053-2991aa0ac857 | 2026-07-27 | Warnings, Adverse reactions | 2059266 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 75d68f19-4208-109e-e053-2991aa0ac857 | Tiglutik 50 MG in 10 mL Oral Suspension [PSN] · riluzole 5 MG/ML Oral Suspension [Tiglutik] [SBD] · Tiglutik 25 MG per 5 ML Oral Suspension [SY] · Tiglutik 5 MG/ML Oral Suspension [SY] · Tiglutik 50 MG per 10 ML Oral Suspension [SY] | 5 | 21 | These highlights do not include all the information needed to use TIGLUTIK® safely and effectively. See full prescribing information for TIGLUTIK. TIGLUTIK (riluzole) oral suspension Initial U.S. Approval: 1995 | 20251231 |